Our Clinical Trial Experience With Ebola Virus Disease

  • Post author:
  • Post category:

Since 1976, Ebola virus disease outbreaks have primarily occurred in eleven countries: Democratic Republic of the Congo, Gabon, Guinea, Liberia, Mali, Nigeria, Republic of Congo, Sierra Leone, Sudan and Uganda. Although it is generally rare, it is often fatal, with death rates ranging from 25 to 90% in past outbreaks (average case fatality rate, 50%). No treatment or vaccine is currently approved, but there are several promising vaccines and treatments under development.

Continue ReadingOur Clinical Trial Experience With Ebola Virus Disease

Providing Site Monitoring and Management Expertise in Malaria Vaccine Trials in Equatorial Guinea

  • Post author:
  • Post category:

Data monitoring strategies implemented by our bilingual CRA helped eliminate the backlog to ensure timely database lock in a phase 2 trial for Sanaria's innovative PfSPZ Vaccine for malaria in Equatorial Guinea, an area with limited prior research experience.

Continue ReadingProviding Site Monitoring and Management Expertise in Malaria Vaccine Trials in Equatorial Guinea

Our Clinical Trial Experience With Chikungunya Virus

  • Post author:
  • Post category:

CHIKV outbreaks have occurred in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. It was found for the first time in the Americas on islands in the Caribbean in 2013 and has spread throughout most of the Americas. It has since been identified in over 60 countries in Asia, Africa, Europe and the Americas. No commercially available vaccine to prevent or medicine to treat CHIKV infection is currently available.

Continue ReadingOur Clinical Trial Experience With Chikungunya Virus